Mycobacterium malmoense: Difference between revisions

Jump to navigation Jump to search
Shanshan Cen (talk | contribs)
No edit summary
 
Shanshan Cen (talk | contribs)
Line 41: Line 41:
==Treatment==
==Treatment==
===Antimicrobial regimen===
===Antimicrobial regimen===
* in vitro <ref>{{Cite journal| doi = 10.1164/rccm.200604-571ST| issn = 1073-449X| volume = 175| issue = 4| pages = 367–416| last1 = Griffith| first1 = David E.| last2 = Aksamit| first2 = Timothy| last3 = Brown-Elliott| first3 = Barbara A.| last4 = Catanzaro| first4 = Antonino| last5 = Daley| first5 = Charles| last6 = Gordin| first6 = Fred| last7 = Holland| first7 = Steven M.| last8 = Horsburgh| first8 = Robert| last9 = Huitt| first9 = Gwen| last10 = Iademarco| first10 = Michael F.| last11 = Iseman| first11 = Michael| last12 = Olivier| first12 = Kenneth| last13 = Ruoss| first13 = Stephen| last14 = von Reyn| first14 = C. Fordham| last15 = Wallace| first15 = Richard J.| last16 = Winthrop| first16 = Kevin| last17 = ATS Mycobacterial Diseases Subcommittee| last18 = American Thoracic Society| last19 = Infectious Disease Society of America| title = An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases| journal = American Journal of Respiratory and Critical Care Medicine| date = 2007-02-15| pmid = 17277290}}</ref>
:* Susceptible: [[Ethambutol]], [[Ethionamide]], [[Kanamycin]], and [[Cycloserine]]
:* Resistant: [[INH]], [[Streptomycin]], [[Rifampin]], and [[Capreomycin]]
* Pulmonary M. malmoense infection
:* Preferred regimen: [[INH]] {{and}} [[Rifampin]] {{and}} [[Ethambutol]] {{withorwithout}} [[Quinolones]] {{and}} [[Macrolides]]


==References==
==References==

Revision as of 18:46, 6 July 2015

Mycobacterium malmoense
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. malmoense
Binomial name
Mycobacterium malmoense
Schroder and Juhlin 1977, ATCC 29571

Mycobacterium malmoense is a bacteria.
Etymology: malmoense, from the city of Malmö, Sweden where it was first isolated.

Description

Gram-positive, nonmotile, acid-fast and coccoid to short rods.

  • Environmental reservoir: soil and water.

Colony characteristics

  • Smooth and nonpigmented colonies, growth below the surface of semisolid agar medium after deep inoculation (as seen with M. bovis), 0.9 - 1.7mm in diameter.

Physiology

Differential characteristics

Pathogenesis

Type Strain

Strain ATCC 29571 = CCUG 37761 = CIP 105775 = DSM 44163 = JCM 13391 = NCTC 11298.

Treatment

Antimicrobial regimen

  • Pulmonary M. malmoense infection

References

  1. Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A.; Catanzaro, Antonino; Daley, Charles; Gordin, Fred; Holland, Steven M.; Horsburgh, Robert; Huitt, Gwen; Iademarco, Michael F.; Iseman, Michael; Olivier, Kenneth; Ruoss, Stephen; von Reyn, C. Fordham; Wallace, Richard J.; Winthrop, Kevin; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007-02-15). "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases". American Journal of Respiratory and Critical Care Medicine. 175 (4): 367–416. doi:10.1164/rccm.200604-571ST. ISSN 1073-449X. PMID 17277290.
  • Schroder,K., I. Juhlin 1977. Mycobacterium malmoense sp. nov. International Journal of Systematic Bacteriology, 1977, 27, 241-246.]

Template:Bacteria-stub

de:Mycobacterium malmoense nl:Mycobacterium malmoense